TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02926651

Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

The sponsor gave no reason.

Life of this trial

2016201720182019202020212022Registered2016-10-04Planned start2016-10 (planned)Withdrawn (as of)2021-10-26

Vital statistics

Status
Withdrawn
Phase
Phase 4
Sponsor
Rush University Medical Center
Sponsor type
University, hospital or other
Conditions
Anemia; Arthritis; Total Knee Arthroplasty; Total Hip Arthroplasty
Interventions
Conventional Oral TXA (Tranexamic Acid); Multi-Dose Oral TXA (Tranexamic Acid)
Participants
0
Sites
1
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.